Singapore markets close in 3 hours 8 minutes

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
23.650+1.100 (+4.88%)
As of 01:33PM HKT. Market open.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

45 Sha Mian North Street
Liwan District
Guangzhou 510130
China
86 20 6628 1218
https://www.gybys.com.cn

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees25,437

Key executives

NameTitlePayExercisedYear born
Mr. Chuyuan LiExec. ChairmanN/AN/A1966
Mr. Hong LiGM & Exec. Director238.15kN/A1967
Ms. Ning ChengVice ChairmanN/AN/A1966
Mr. Jun YangVice ChairmanN/AN/A1970
Mr. Changhai WuDeputy GM & Exec. Director178.59kN/A1966
Ms. Juyan LiuExec. DirectorN/AN/A1964
Mr. Zhang ChunboDeputy GM & Exec. Director146.55kN/A1977
Ms. Haoshan ZhengDeputy GM & Director of Bus. Admin. DepartmentN/AN/A1976
Mr. Jianxiong ZhengDeputy Gen. Mang.N/AN/A1970
Ms. Xuezhen HuangSec.N/AN/A1974
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Corporate governance

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s ISS governance QualityScore as of 1 December 2022 is 1. The pillar scores are Audit: 8; Board: 3; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.